Subtitle: Over the summer, three promising doctoral students began their Ruth L. Kirschstein National Institute of Health research fellowships. They will be mentored by faculty sponsors while conducting their research in health-related fields. January 10, […]
The new year is bringing new progress toward the establishment of Duquense University’s College of Osteopathic Medicine, which would be Pittsburgh’s second medical school when it is expected to open in the fall of 2024. […]
CAMARILLO, Calif.: CAMARILLO, Calif., Jan. 10, 2022 /PRNewswire/ — SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey. […]
Merck, eyes on Roche’s immunotherapy first, returns perplexing Keytruda post-surgery lung cancer data aliu Mon, 01/10/2022 – 09:43 Click here to view original post
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo kdunleavy Mon, 01/10/2022 – 08:09 Click here to view original post
Since coming into a massive windfall with its Covid-19 vaccines, Moderna has been looking for ways to expand its mRNA technologies into other promising areas. On Monday, the biotech took its next step toward that […]
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because that oh-so familiar routine of online calls, deadlines, and planning has predictably returned. But what can […]
PLYMOUTH MEETING, Pa.: New NCCN Guidelines for Patients: Graft-Versus-Host Disease offers clarity and consensus on how best to address and treat a common and complex immune response side-effect from stem cell transplants. PLYMOUTH MEETING, Pa., […]
EXTON, Pa.: EXTON, Pa., Jan. 10, 2022 /PRNewswire/ — Castle Creek Biosciences, Inc., a late-clinical stage cell and gene therapy company focused on developing and preparing to commercialize disease-modifying and potentially curative therapies for rare […]
RADNOR, Pa.: RADNOR, Pa., Jan. 10, 2022 /PRNewswire/ — The approval of QUVIVIQ™ – 25 & 50 mg – is based on a robust Phase 3 clinical program that demonstrated significant improvement versus placebo on […]
Copyright © 2023 Biotech Networks, LLC
